Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities
Net loss	$ (156,902)	$ (269,901)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense	35,947	14,534
Stock-based compensation	658	9,272
Lease impairment loss	7,616	0
(Gain)/Loss on disposal on property, plant and equipment	(71)	3,698
Change in fair value of related party notes payable and related party warrant liabilities	339	(384)
Change in fair value of notes payable and warrant liabilities	(20,640)	(72,930)
Change in fair value measurement of earnout liability	0	2,100
Amortization of operating lease right-of-use asset	1,468	1,419
Loss on foreign exchange	287	164
(Gain) Loss on forgiveness of accounts payable and deposits, net	(518)	135
Non-cash interest expense	1,282	0
Other	0	669
Changes in operating assets and liabilities:
Deposits	3,561	(17,767)
Inventory	5,484	(5,844)
Other current and non-current assets	9,620	2,977
Accounts payable	(1,908)	9,905
Financial obligations on sale and lease back transaction	1,353	0
Accrued expenses and other current liabilities	7,624	(27,551)
Operating lease liabilities	(2,081)	(1,097)
Accrued related party interest expense	5,114	(127)
Net cash used in operating activities	(29,091)	(160,708)
Cash flows from investing activities
Proceeds from sale of equipment	87	0
Purchase of property, plant and equipment	(358)	(25,852)
Net cash used in investing activities	(271)	(25,852)
Cash flows from financing activities
Proceeds from exercise of warrants	0	4,074
Payments of notes payable	(12)	0
Payments of finance lease obligations	0	(673)
Proceeds from exercise of stock options	0	44
Net cash provided by financing activities	26,715	181,838
Effect of exchange rate changes on cash and restricted cash	(1)	5,604
Net change in cash and restricted cash	(2,648)	882
Cash and restricted cash, beginning of period	4,025	18,514
Cash and restricted cash, end of period	1,377	19,396
Cash and restricted cash
Cash	793	17,893
Restricted cash	584	1,503
Total cash and restricted cash	1,377	19,396
Supplemental disclosure of noncash investing and financing activities
Additions of property, plant and equipment included in accounts payable and accrued expenses	42,690	20,047
Reclassification of February 28, 2023 stock-based awards liability to equity due to authorized share increase	0	8,978
Issuance of SPA Warrants	10	30,348
Reduction in outstanding warrants pursuant to the Exchange Agreement	0	16,506
Issuance of Secured SPA Notes pursuant to the Exchange Agreement	0	16,500
Change in classification of warrants from Additional paid-in capital to liability pursuant to the Warrant Exchange	0	6,811
Reclassification of February 28, 2023 earnout shares liability to equity due to authorized share increase	0	5,014
Reclassification of earnout shares from equity to liability on April 21, 2023 due to insufficient authorized shares	0	2,112
Reclassification of stock-based awards from equity to liability on April 21, 2023 due to insufficient authorized shares	0	2,979
Supplemental disclosure of cash flow information
Cash paid for interest	465	465
Nonrelated Party
Supplemental disclosure of noncash investing and financing activities
Conversion of notes payable, related party notes payable and accrued interest into Class A Common Stock (as restated)	17,240	106,458
Nonrelated Party
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on settlement of notes payable	58,381	183,528
Cash flows from financing activities
Proceeds from notes payable, net of original issuance discount	23,916	160,800
Settlement of notes payable transaction costs	(189)	(1,834)
Related Party
Adjustments to reconcile net loss to net cash used in operating activities:
Loss on settlement of notes payable	14,295	6,492
Cash flows from financing activities
Proceeds from related party notes payable	3,000	19,782
Settlement of notes payable transaction costs	$ 0	$ (355)